CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jan. 26, 2013	Jan. 28, 2012
Net income	$ 14,959	$ 15,883
Depreciation and amortization	9,942	9,632
Deferred taxes	(3,310)	(700)
Provision to value inventories at LIFO	300	560
Non-cash share-based compensation	1,613	1,576
Income from partnerships	(1,450)
Change in merchandise inventories	(1,760)	(3,862)
Change in patronage dividend receivable	5,950	4,787
Change in accounts payable to Wakefern	2,738	195
Change in accounts payable and accrued expenses	(1,854)	(6,019)
Change in income taxes payable	6,119	764
Change in other assets and liabilities	(2,491)	(211)
Net cash provided by operating activities	30,756	22,605
Capital expenditures	(10,077)	(10,059)
Investment in notes receivable from Wakefern	(745)	(694)
Proceeds from partnerships	1,980
Net cash used in investing activities	(8,842)	(10,753)
Proceeds from exercise of stock options	598	305
Excess tax benefit related to share-based compensation	241	41
Principal payments of long-term debt	(1,281)	(782)
Dividends	(18,000)	(4,011)
Net cash used in financing activities	(18,442)	(4,447)
NET INCREASE IN CASH AND CASH EQUIVALENTS	3,472	7,405
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	103,103	91,362
CASH AND CASH EQUIVALENTS, END OF PERIOD	106,575	98,767
Cash payments for interest	2,004	2,114
Cash payments for income taxes	7,785	11,477
Non-cash investment in Wakefern	$ 949	$ 269